专利检索 ap:("LFB BIOTECHNOLOGIES" OR "CENTRE NATIONAL DE LUTTE CONTRE LE CANCER" OR "I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE" OR "UNIVERSITE MONTPELLIER 1") AND inv:"Isabelle Navarro-Teulon" 第 1 页

1.

发明授权
Pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type II 有权
标题翻译：药物组合物，其包含结合人类抗髓激素受体II型的抗体

公开(公告)号：US09511138B2

公开(公告)日：2016-12-06

申请号：US14367969

申请日：2012-12-21

申请人： LFB BIOTECHNOLOGIES , CENTRE NATIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE , UNIVERSITE MONTPELLIER 1

发明人： Christine Gaucher , Isabelle Navarro-Teulon

IPC分类号： A61K39/395 , A61K31/337 , A61K31/282 , C07K16/28 , A61K45/06 , A61K33/24

CPC分类号： C07K16/2869 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K33/24 , A61K39/39533 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/28 , C07K16/3069 , C07K2317/24 , C07K2317/92 , A61K2300/00

摘要： The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.

摘要翻译： 本发明涉及包含作为活性成分的结合人类抗Müllerian激素II型受体（AMHR-II）和抗癌剂的新型药物组合物，以及这些组合物的治疗应用。

2.

发明授权
Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II 有权

公开(公告)号：US10179816B2

公开(公告)日：2019-01-15

申请号：US15333519

申请日：2016-10-25

申请人： LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES , CENTRE REGIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE MONTPELLIER 1

发明人： Christine Gaucher , Isabelle Navarro-Teulon

IPC分类号： A61K39/395 , C07K16/28 , A61K31/282 , A61K31/337 , A61K45/06 , A61K33/24 , A61K9/00 , C07K16/30 , A61K39/00

摘要： The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.

3.

发明授权
Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II 有权

公开(公告)号：US09637544B2

公开(公告)日：2017-05-02

申请号：US14658785

申请日：2015-03-16

申请人： LFB BIOTECHNOLOGIES , UNIVERSITE MONTPELLIER I , CENTRE NATIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)

发明人： Christian Behrens , Isabelle Navarro-Teulon

IPC分类号： C07K16/28 , G01N33/574 , A61K39/395 , A61K45/06 , A61K39/00

CPC分类号： C07K16/2863 , A61K31/282 , A61K31/337 , A61K31/7088 , A61K33/24 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/2869 , C07K16/46 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/64 , C07K2317/73 , C07K2317/732 , C07K2317/92 , G01N33/57449 , G01N2333/72

摘要： Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor.